首页|期刊导航|国际肝胆健康（英文）|Convergent systemic therapy for liver metastases:Bridging primary tumor heterogeneity through shared pathways

Convergent systemic therapy for liver metastases:Bridging primary tumor heterogeneity through shared pathways

Wenjing Wang Caiyun Peng Hongli Yu Jiamin Cheng Zhipeng Liang Yinying Lu Zhixian Hong

国际肝胆健康（英文）Issue(4)：48-53,6.

国际肝胆健康（英文）Issue(4)：48-53,6.DOI:10.1016/j.iliver.2025.100204

Convergent systemic therapy for liver metastases:Bridging primary tumor heterogeneity through shared pathways

Wenjing Wang ¹Caiyun Peng ²Hongli Yu ¹Jiamin Cheng ¹Zhipeng Liang ²Yinying Lu ¹Zhixian Hong³

作者信息

1. Senior Department of Hepatology,The Fifth Medical Center,Chinese PLA General Hospital,Beijing 100039,China
2. Senior Department of Hepatology,Chinese PLA General Hospital,Beijing 100039,China
3. The Clinical Medical School,Guizhou Medical University,Guiyang 561113,Guizhou,China
折叠

摘要

关键词

Liver metastases/Systemic therapy/Treatment strategy

Key words

Liver metastases/Systemic therapy/Treatment strategy

引用本文复制引用

Wenjing Wang,Caiyun Peng,Hongli Yu,Jiamin Cheng,Zhipeng Liang,Yinying Lu,Zhixian Hong..Convergent systemic therapy for liver metastases:Bridging primary tumor heterogeneity through shared pathways[J].国际肝胆健康（英文）,2025,(4):48-53,6.

基金项目

This research was funded by the Noncommunicable Chronic Dis-eases-National Science and Technology Major Project,grant number 2024ZD0526200. （）

国际肝胆健康（英文）

访问量1

下载量0

段落导航